In the last decade, AI has taken the field of neurology by storm. It has particularly revolutionised the way that Parkinson’s is diagnosed, researched, and managed. Lina Adams explores the technological advances that are underway as researchers aim to understand more about Parkinson’s pathology.

Top News

4. Millions invited for COVID-19 booster jabs in England and Scotland 
Millions of people have been invited for their autumn COVID-19 booster jab in England and Scotland as of Monday 5 September, and care home residents will be the first to receive this vaccine.
6. Yeast cells engineered to fight cancer
A team of scientists at the Technical Universty of Denmark have genetically engineered yeast to recreate vinblastine, an anti-cancer drug which was in short supply between 2019-21.
8. China approves world’s first inhaled COVID-19 vaccine for emergency use
China has become the first country to approve an inhaled COVID-19 vaccine, paving the way for potential use of the needle-free product in the country.
Pharmafocus speaks to Eoin O’Carroll, cofounder and CEO of oncology platform ONCOAssist, about the importance of digital platforms in this complex and ever-evolving field.

Our Team

Executive Director – PMGroup Worldwide Ltd
Karl Equi
Group Managing Editor
Iona Everson
Editorial and Content Assistant
Lina Adams
Sales Manager
Eliot Haynes
Design & Layout
Peter May
Pharmafocus is published by:
Samedan Ltd
Suite E, 11 Bell Yard Mews,
175 Bermondsey Street,
London, SE1 3TN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Subscriptions & Data Management
Curwood CMS Tel: 01580 883840
ISSN: 1465-5403
Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).
All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.
©2022 Samedan Ltd, Pharmaceutical Publishers
The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.